Concepedia

Publication | Closed Access

Omalizumab in the treatment of allergic bronchopulmonary aspergillosis: One center's experience with 14 cases

DOI

47

Citations

0

References

2015

Year

Ömür Aydın, Zeynep Çelebi Sözener, Şadan Soyyiğit, Reşat Kendirlinan, Zeynep Gençtürk, Zeynep Mısırlıgil, Dilşad Mungan, Betül Ayşe Sin, Yavuz Selim Demirel, Gülfem Çelík,
Allergy and Asthma Proceedings

Abstract

Omalizumab provided a clinically important reduction in exacerbations and steroid requirement, and improved asthma symptoms and pulmonary function parameters in patients with asthma and ABPA who had previously shown an unsatisfactory response to Global Initiative for Asthma step 4 treatment.